UNLABELLED: Because of the ultrashort tracer half-life and high positron energy of (82)Rb, PET images acquired with this tracer are noisier and of lower resolution than those obtained with other PET tracers. The validity of electrocardiographic gating using (82)Rb for assessment of left ventricular (LV) function is not well established. To support feasibility, we compared functional parameters from gated (82)Rb PET with simultaneous high-resolution contrast-enhanced CT ventriculography, obtained as a byproduct a CT coronary angiography during hybrid cardiac PET/CT. METHODS: A total of 24 patients underwent PET/CT, consisting of rest and dipyridamole (82)Rb perfusion studies and contrast-enhanced CT angiography, using a 64-slice scanner, for the workup of coronary artery disease. From gated PET images, LV ejection fraction (EF), end-diastolic volume (EDV), and end-systolic volume (ESV) were calculated using 2 commercial products. For functional CT analysis, commercial software using endocardial contour detection was applied. RESULTS: Inter- and intraobserver agreement was good for all methods. On CT, EF was 66% +/- 13%, ESV was 41 +/- 29 mL, and EDV was 115 +/- 36 mL. On PET, EF during dipyridamole was 56% +/- 15% and 52% +/- 15% using the 2 commercial products (P < 0.05 vs. CT), ESV was 36 +/- 28 and 47 +/- 35 mL (P = not significant vs. CT), and EDV was 75 +/- 30 and 91 +/- 33 mL (P < 0.05 vs. CT). Correlations with CT were 0.85 and 0.87 for EF using commercial software, 0.76 and 0.88 for ESV, and 0.60 and 0.68 for EDV (P < 0.01 for all). Bland-Altman analysis confirmed systematic underestimation of EF and EDV by PET versus CT but did not show a significant deviation from linearity. CONCLUSION: Global LV function can be measured reproducibly from gated (82)Rb PET, using different available software products. However, underestimation of EF by (82)Rb PET, compared with CT ventriculography, is present, which is a result of underestimation of EDV from count-poor ED frames. This underestimation needs to be considered for clinical interpretation of (82)Rb PET.
UNLABELLED: Because of the ultrashort tracer half-life and high positron energy of (82)Rb, PET images acquired with this tracer are noisier and of lower resolution than those obtained with other PET tracers. The validity of electrocardiographic gating using (82)Rb for assessment of left ventricular (LV) function is not well established. To support feasibility, we compared functional parameters from gated (82)Rb PET with simultaneous high-resolution contrast-enhanced CT ventriculography, obtained as a byproduct a CT coronary angiography during hybrid cardiac PET/CT. METHODS: A total of 24 patients underwent PET/CT, consisting of rest and dipyridamole (82)Rb perfusion studies and contrast-enhanced CT angiography, using a 64-slice scanner, for the workup of coronary artery disease. From gated PET images, LV ejection fraction (EF), end-diastolic volume (EDV), and end-systolic volume (ESV) were calculated using 2 commercial products. For functional CT analysis, commercial software using endocardial contour detection was applied. RESULTS: Inter- and intraobserver agreement was good for all methods. On CT, EF was 66% +/- 13%, ESV was 41 +/- 29 mL, and EDV was 115 +/- 36 mL. On PET, EF during dipyridamole was 56% +/- 15% and 52% +/- 15% using the 2 commercial products (P < 0.05 vs. CT), ESV was 36 +/- 28 and 47 +/- 35 mL (P = not significant vs. CT), and EDV was 75 +/- 30 and 91 +/- 33 mL (P < 0.05 vs. CT). Correlations with CT were 0.85 and 0.87 for EF using commercial software, 0.76 and 0.88 for ESV, and 0.60 and 0.68 for EDV (P < 0.01 for all). Bland-Altman analysis confirmed systematic underestimation of EF and EDV by PET versus CT but did not show a significant deviation from linearity. CONCLUSION: Global LV function can be measured reproducibly from gated (82)Rb PET, using different available software products. However, underestimation of EF by (82)Rb PET, compared with CT ventriculography, is present, which is a result of underestimation of EDV from count-poor ED frames. This underestimation needs to be considered for clinical interpretation of (82)Rb PET.
Authors: David T Chien; Paco Bravo; Takahiro Higuchi; Jennifer Merrill; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2011-04-29 Impact factor: 9.236
Authors: Christoph Kolbitsch; Mark A Ahlman; Cynthia Davies-Venn; Robert Evers; Michael Hansen; Devis Peressutti; Paul Marsden; Peter Kellman; David A Bluemke; Tobias Schaeffter Journal: J Nucl Med Date: 2017-02-09 Impact factor: 10.057
Authors: Nils Henrik Hansson; Lars Tolbod; Hendrik Johannes Harms; Henrik Wiggers; Won Yong Kim; Esben Hansen; Tomas Zaremba; Jørgen Frøkiær; Steen Jakobsen; Jens Sørensen Journal: J Nucl Cardiol Date: 2016-04-19 Impact factor: 5.952
Authors: Riikka Lautamäki; Richard T George; Kakuya Kitagawa; Takahiro Higuchi; Jennifer Merrill; Corina Voicu; Anthony DiPaula; Stephan G Nekolla; João A C Lima; Albert C Lardo; Frank M Bengel Journal: Eur J Nucl Med Mol Imaging Date: 2008-11-05 Impact factor: 9.236
Authors: Kenji Fukushima; Paco E Bravo; Takahiro Higuchi; Karl H Schuleri; Xiaoping Lin; M Roselle Abraham; Jinsong Xia; William B Mathews; Robert F Dannals; Albert C Lardo; Zsolt Szabo; Frank M Bengel Journal: J Am Coll Cardiol Date: 2012-11-14 Impact factor: 24.094
Authors: Yuan Xu; Paul Kavanagh; Mathews Fish; James Gerlach; Amit Ramesh; Mark Lemley; Sean Hayes; Daniel S Berman; Guido Germano; Piotr J Slomka Journal: J Nucl Med Date: 2009-08-18 Impact factor: 10.057
Authors: Jing Tang; Arman Rahmim; Riikka Lautamäki; Martin A Lodge; Frank M Bengel; Benjamin M W Tsui Journal: Phys Med Biol Date: 2009-05-06 Impact factor: 3.609
Authors: A Rahmim; J Tang; M A Lodge; S Lashkari; M R Ay; R Lautamäki; B M W Tsui; F M Bengel Journal: Phys Med Biol Date: 2008-10-03 Impact factor: 3.609